When the remedy becomes the illness: differentiating hyperemesis gravidarum versus cannabinoid hyperemesis syndrome in pregnancy and nutritional consequences
Authors:
- 5 October 2026
- journal article
- case report
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 124 (5) , 101505
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Prenatal Cannabis Use and Neonatal OutcomesJAMA Pediatrics, 2025
- The impact and management of hyperemesis gravidarum: Current and future perspectivesInternational Journal of Gynecology & Obstetrics, 2025
- Prenatal Cannabis Use and Maternal Pregnancy OutcomesJAMA Internal Medicine, 2024
- The importance of nutrition in pregnancy and lactation: lifelong consequencesAmerican Journal of Obstetrics and Gynecology, 2021
- Hyperemesis gravidarum is associated with increased rates of termination of pregnancy and suicidal ideation: results from a survey completed by >5000 participantsAmerican Journal of Obstetrics and Gynecology, 2021
- Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United StatesJAMA, 2019
- Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency DepartmentThe Journal of Emergency Medicine, 2018
- Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Safety of home parenteral nutrition during pregnancyClinical Nutrition, 2017
- Diagnostic criteria for cannabis withdrawal syndromeDrug and Alcohol Dependence, 2012